Market Overview:
The Revision Knee Replacement Market was valued at USD 11,630 million in 2024 and is anticipated to reach USD 17,552.81 million by 2032, growing at a compound annual growth rate (CAGR) of 5.28% during the forecast period (2024-2032).
The market growth is primarily driven by the increasing prevalence of osteoarthritis and rheumatoid arthritis, leading to a higher number of primary knee replacements and subsequent revision surgeries. Longer life expectancy and the growing participation in high-impact physical activities contribute to implant wear and tear, creating a need for revision procedures. Furthermore, the rising number of younger patients undergoing primary knee replacements adds to the demand for revision surgeries, as these implants may require replacement within the patient's lifetime. Increasing obesity rates are also accelerating joint degeneration, further driving the need for knee revision procedures. The adoption of minimally invasive and robotic-assisted surgical techniques is enhancing precision and reducing recovery times, further contributing to market growth. However, high procedure costs, risks of complications, and limited reimbursement policies in certain regions may pose challenges to market expansion.
Market Drivers
Growing Cases of Implant Wear and Younger Patient Demographics:
The market is significantly driven by the increasing number of younger patients undergoing primary knee replacement surgeries. Younger individuals, who tend to have more active lifestyles, are more likely to experience implant wear over time, thus requiring revision surgeries. According to Dr. James I. Huddleston III, chair of the American Joint Replacement Registry (AJRR) Steering Committee, the AJRR’s 2024 report reveals data on more than 3.7 million hip and knee arthroplasty procedures performed at 1,447 institutions. The rising life expectancy and participation in high-impact activities, coupled with younger patient demographics, contribute to implant deterioration, thereby increasing the demand for revision knee replacements.
Market Challenges Analysis
High Procedure Costs and Limited Reimbursement Coverage:
One of the main challenges in the revision knee replacement market is the high cost associated with these procedures. Revision surgeries are generally more complex than primary knee replacements, often requiring specialized implants, advanced surgical techniques, and longer hospital stays. These factors significantly increase the overall treatment costs, making the procedure less accessible to patients, especially in regions with limited healthcare funding. Additionally, restrictive reimbursement policies in many countries place a financial burden on patients, limiting the adoption of revision knee replacements. In many healthcare systems, primary knee replacements receive higher priority for coverage, while revision surgeries often face greater out-of-pocket expenses, further hindering market growth, particularly in developing economies where healthcare budgets are constrained.
Segmentations
By Product Type:
Uni-compartmental
Three Compartmental
By Fixation Type:
Cementless
Cemented
By End User:
Orthopaedic and Prosthetic Clinics
Hospitals
Others
By Region:
North America:
U.S.
Canada
Mexico
Europe:
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific:
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America:
Brazil
Argentina
Rest of Latin America
Middle East & Africa:
GCC Countries
South Africa
Rest of the Middle East and Africa
Key Player Analysis
Smith & Nephew Plc
Braun Melsungen AG
Wright Medical Group, Inc.
Zimmer Holdings; Biomet, Inc.
Exactech
DePuy Companies, Inc.
Ortho Development
Limacorporate S.p.a.
Stryker Corporation
DJO Global
SURGIVAL INTERNATIONAL
BEZNOSKA
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook